AKAO 2017 Annual Report

82 3/12/2014 12/31/2014 12/31/2015 12/31/2016 12/31/2017 $- $20 $40 $60 $80 $100 $120 $140 $160 $180 Achaogen, Inc. NASDAQ Composite Index NASDAQ Biotechnology Index Comparison of Cumulative Total Return Ticker March 12, 2014 December 31, 2014 December 31, 2015 December 31, 2016 December 31, 2017 Achaogen, Inc........................... AKAO $ 100 $ 91 $ 40 $ 91 $ 75 Nasdaq Composite Index.......... IXIC $ 100 $ 111 $ 118 $ 129 $ 164 Nasdaq Biotechnology Index ... NBI $ 100 $ 117 $ 130 $ 103 $ 122 Holders of Common Stock As of February 23, 2018, there were approximately 15 holders of record of our common stock. This number does not include beneficial owners whose shares are held by nominees in street name. Dividend Policy We have never declared or paid cash dividends on our capital stock. We intend to retain all available funds and any future earnings, if any, to fund the development and expansion of our business and we do not anticipate paying any cash dividends in the foreseeable future. Any future determination related to dividend policy will be made at the discretion of our board of directors. Recent Sales of Unregistered Securities From January 1, 2017 through December 31, 2017, other than as indicated in the paragraph below, we have not issued any securities in a transaction not registered under the Securities Act that have not been previously disclosed in a Quarterly report on Form 10-Q or Current Report on Form 8-K.